Ultima Genomics Offers 3 Trillion Free Sequencing Reads to Support the Scientific Community

Applications Now Open to Researchers

FREMONT, Calif., April 1, 2025 /PRNewswire/ -- Ultima Genomics, Inc., developer of an ultra-high-throughput sequencing architecture, today announced the launch of its "Count on Us" initiative. During the month of April, Ultima Genomics will provide 3 trillion DNA sequencing reads free of charge to researchers across the U.S. and Canada.

As part of the "Count on Us" initiative, researchers affiliated with academic, public, government, or other non-profit institutions can apply for a share of 3 trillion sequencing reads—equivalent to approximately 9,000 human genomes at 30x coverage—at no cost. Applications open today and will be accepted on a rolling basis through April 30, 2025.

"It has always been Ultima's mission to make sequencing more accessible and affordable to the scientific community," said Gilad Almogy, founder and CEO of Ultima Genomics. "With research budgets in flux and uncertainty facing many labs, we want scientists to know they can count on us to help keep their work moving forward. With our competitive pricing and growing global Certified Service Providers network, our UG 100 is well-positioned to power the next wave of genomics. This initiative reflects our belief that cost constraints shouldn't limit science, especially when critical discoveries are on the line."

Eligible projects will receive between 10 billion and 100 billion reads (up to 300 bp each), equivalent to 1 to 10 wafers run on the UG 100™ sequencing platform. Researchers are asked to provide Ultima-compatible libraries and submit project proposals of up to 250 words. Preference will be given to projects at risk due to recent unexpected budget cuts. Sequencing data is to be delivered via S3 buckets or GCP, and the output is compatible with standard analysis pipelines. Awards are granted on a rolling basis. Due to the expected high demand, early submissions are encouraged.

Ultima supports a wide range of applications, including:

• Single Cell | 10x Genomics (3', 5', FLEX), Parse (Evercode WT v2/v3), Scale (QuantumScale)
• Proteomics (Olink Explore HT)
• Whole Genome Sequencing (human and non-human: PCR-free, ppmSeq, cfDNA, MethylSeq, FFPE, Low-Pass/Twist)
• RNA-Seq
• Spatial transcriptomics (Visium HD)

Submissions are limited to new customers, and only one application per PI/lab is allowed. All libraries must be shipped in a single batch and received by June 30, 2025. Interested applicants can submit an application here.

About Ultima Genomics

Ultima Genomics is unleashing the power of genomics at scale. The Company's mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology's complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century. To learn more, visit www.ultimagenomics.com.

Media Contact

Vikki Herrera
408-206-7009
[email protected]

SOURCE Ultima Genomics